Leerink Partners analyst David Risinger has maintained their bullish stance on BMY stock, giving a Buy rating on November 19.Don't Miss our ...

Hubble Space Telescope observations of white dwarf star G238-44 has shown that it is "consuming both rocky-metallic and icy ...

Leerink analyst David Risinger upgraded AbbVie (ABBV) to Outperform from Market Perform with a $206 price target The firm ...

Analyst David Risinger of Leerink Partners reiterated a Buy rating on Eli Lilly & Co (LLY – Research Report), retaining the price target of ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...

The drug, called icotrokinra and developed together with Protagonist Therapeutics, is an oral peptide designed to tamp down ...

Sagittarius A* has been seen by human eyes with an "image produced by a global research team called the Event Horizon ...

Two weeks after Election Day, Peoria County learned who had been elected as the next circuit judge for the county. John ...

Lilly’s muvalaplin is the first oral drug to show positive Phase II findings for Lp(a) reduction, eliciting up to an 86% drop ...

Beaumont ISD's Maritime Program equips students with skills for careers on the water, offering certifications and ...

Black Gotham Experience (BGX), the Lower Manhattan-based immersive visual storytelling project that commemorates the impact ...

The Greyhounds have shrugged off a slow start and are now above .500 for the first time this season, having won three ...